Immuron Ltd
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
other
SEC Category
Non-accelerated filer
State of Incorporation
Australia
Business Address
62 LYGON STREET, CARLTON, VICTORIA, C3, 3053
Mailing Address
62 LYGON STREET, CARLTON, VICTORIA, C3, 3053
Phone
61 03 9824 5254
Fiscal Year End
0630
EIN
000000000
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 6-K Foreign company current report | March 5, 2026 | View on SEC |
| 6-K Foreign company current report | March 2, 2026 | View on SEC |
| 6-K Foreign company current report | February 17, 2026 | View on SEC |
| 6-K Foreign company current report | February 12, 2026 | View on SEC |
| 6-K Foreign company current report | February 9, 2026 | View on SEC |
| 6-K Foreign company current report | January 23, 2026 | View on SEC |
| 6-K Foreign company current report | January 20, 2026 | View on SEC |
| 6-K Foreign company current report | January 14, 2026 | View on SEC |
| 6-K Foreign company current report | January 12, 2026 | View on SEC |
| 6-K Foreign company current report | December 16, 2025 | View on SEC |
Annual Reports
20-F
September 25, 2025
- Net loss decreased to $1.15 million from $4.8 million due to improved cost control
- 6.43 million stock options granted to executives in 2024, over five times 2021-2023 total
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.